Global Nanomedicine Market Report 2021
November 02, 2021 10:08 ET
|
Research and Markets
Dublin, Nov. 02, 2021 (GLOBE NEWSWIRE) -- The market is expected to grow to reach $361.44 billion in 2025 according to the "Nanomedicine Global Market Report 2021: COVID-19 Growth and Change" report...
Cello Therapeutics’ Platelet Membrane-Coated Nanoparticles Offer a Novel Platform for the Delivery of Immunotherapy in Cancer Treatment
March 31, 2021 22:57 ET
|
Cello Therapeutics, Inc.
SAN DIEGO, March 31, 2021 (GLOBE NEWSWIRE) -- Solid tumors comprise about 90% of all newly diagnosed cancer cases and cancer deaths according to an annual report from the National Cancer Institute....
Karamedica Announces National Institute on Aging Grant to Continue Development of Microparticle Therapy for Cerebral Amyloid Angiopathy
December 15, 2020 07:55 ET
|
Karamedica, Inc.
RALEIGH, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Karamedica, Inc. recently received a $2.5 million Small Business Innovative Research (SBIR) Phase II grant from the National Institute on Aging to...
Arch Therapeutics, Inc. to Present at the Virtual Investor Fireside Chat Series
June 08, 2020 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., June 08, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel wound care and biosurgical devices, today announced that...
UPDATE - Arch Therapeutics Provides Corporate Update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY
October 07, 2019 15:59 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 07, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...
Arch Therapeutics Provides Corporate Update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY
October 07, 2019 11:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 07, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...
Atlas Nanotech of Guadalajara to begin alliance with European Nano Medical S.R.O.
June 27, 2019 00:14 ET
|
COSTAS Inc.
GUADALAJARA, Mexico, June 27, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – CSSI (Costas Inc.) DBA Atlas Nanotech has entered an accord with Nano Medical S.R.O. of the Czech Republic. The first...
COSTAS Inc. (CSSI) Acquires Medical Nanotechnology Company, Appoints New Management and Board Members
June 06, 2019 01:08 ET
|
COSTAS Inc.
LAS VEGAS, June 06, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – COSTAS,Inc. (OTC: CSSI), announces its acquisition of Atlas Nanotech (formerly known as Nano Creaciones SAPI de CV) in an all-stock...
Arch Therapeutics, Inc. $2.8 Million Registered Direct Offering
May 13, 2019 07:45 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH)(“Arch” or the “Company”), a developer of novel liquid, gel and solid hemostatic and wound care devices,...
NANOBIOTIX LEVE ENVIRON 29,5 MILLIONS D’EUROS DANS LE CADRE D’UN PLACEMENT D’ACTIONS ORDINAIRES NOUVELLES
April 09, 2019 02:16 ET
|
Nanobiotix S.A.
NANOBIOTIX LEVE ENVIRON 29,5 MILLIONS D’EUROS DANS LE CADRE D’UN...